Cellular cartography reveals mouse prostate organization and determinants of castration resistance

Hanbyul Cho1,2,3, Yuping Zhang1,2, Jean C Tien1,2

  • 1Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109.

Insights

Prostate cancer resistance to androgen deprivation therapy is poorly understood. This study reveals lobe-specific cell types and androgen-responsive programs in mouse prostates, identifying potential targets for castration resistance.

Area of Science:

  • Genomics and Molecular Biology
  • Cancer Research
  • Developmental Biology

Background:

  • Androgen deprivation therapy (ADT) is a cornerstone treatment for prostate cancer (PCa).
  • Inadequate response and resistance to ADT are significant clinical challenges.
  • The cellular and molecular mechanisms underlying ADT resistance remain incompletely understood.

Purpose of the Study:

  • To define the transcriptional, epigenetic, and spatial basis of cell identity and castration response in the mouse prostate.
  • To identify cellular orthologs and key determinants of ADT response and resistance by integrating mouse and human prostate data.
  • To uncover potential therapeutic targets for countering castration resistance in PCa.

Main Methods:

  • Integration of single-cell RNA sequencing, single-cell multiomics, and spatial transcriptomics in mouse prostate.
  • Meta-analysis of human prostate and PCa datasets.
  • Comparative analysis of cellular identities and transcriptional programs under varying androgen conditions.

Main Results:

  • Mouse prostates exhibit lobe-specific luminal epithelial cell types with distinct gene regulatory modules and androgen-responsive programs.
  • Androgen-insensitive, stem-like cells are enriched in specific prostate regions.
  • Castration induces stress-responsive and stemness programs in castration-resistant luminal epithelial cells, mirroring signatures in human PCa patients.

Conclusions:

  • The study provides a comprehensive cellular atlas of the mouse prostate, highlighting the importance of lobe-specific contexts for PCa modeling.
  • Identified cellular signatures in castration-resistant cells are enriched in human PCa, suggesting their role in treatment failure.
  • The findings reveal potential therapeutic targets to overcome ADT resistance in prostate cancer.